Literature DB >> 1113135

Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system.

B Vandvik, M Degré.   

Abstract

Measles virus hemagglutination-inhibiting (HI) and gel precipitating (GP) antibodies were determined in sera and cerebrospinal fluids (CSF) from 65 patinets with multiple sclerosis (MS) and 65 patients with other neurological diseases. The serological results were correlated to content of immunoglobulin-G (IgG) and electrophoretic patterns of sera and CSF. Measles GP antibodies, identified as directed against measles virus ribonucleoprotein antigens, were detected in sera and in CSF from a significantly higher proportion of MS than of non-MS patients. No significant difference between the 2 groups of patients was found for measles HI antibodies. Reduced serum/CSF HI and/or GP antibody ratios were found in about one half of the MS patients and in 2 patients with chronic myelopathy. All patients with reduced antibody ratios had evidence of IgG synthesis within the central nervous system (CNS), as inferred from oligoclonal IgG patterns of the CSF. Reduced ratios of measles GP antibodies were 3 times as common as reduced ratios of HI antibodies. Immunoelectrophoretic assays indicated that the CSF GP antibodies were electrophoretically restricted in a number of MS patients. The results indicate that measles virus may be an active immunogen within the CNS in many MS patients and in some patients with chronic myelopathy, giving rise to an oligoclonal IgG antibody response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1113135     DOI: 10.1016/0022-510x(75)90233-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Local synovial synthesis of oligoclonal measles virus antibodies and of smooth muscle antibodies in a case of atypical rheumatoid arthritis.

Authors:  B Vandvik; O J Mellbye; E Norrby
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

2.  Immunoglobulin G subclass antibodies to measles virus in patients with subacute sclerosing panencephalitis or multiple sclerosis.

Authors:  P D Mehta; B A Patrick; W Sobczyk; J Kulczycki; J Woyciechowska-Camenga; D Camenga; H Thormar
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  P W Ewan; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis.

Authors:  W P Kaschka; L Theilkaes; K Eickhoff; F Skvaril
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  Measles antibodies and kappa-lambda light chain distribution in immunoglobulins of patients affected with multiple sclerosis.

Authors:  F Bollengier; A Mahler
Journal:  J Neurol       Date:  1979-03-22       Impact factor: 4.849

6.  Relationship between measles virus-specific antibody activities and oligoclonal IgG in the central nervous system of patients with subacute sclerosing panencephalitis and multiple sclerosis.

Authors:  E Norrby; B Vandvik
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

7.  Intrathecal synthesis of virus antibodies in multiple sclerosis patients.

Authors:  T Arnadottir; M Reunanen; A Salmi
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

8.  Measles virus infection and multiple sclerosis: serological studies.

Authors:  W Cendrowski; I Polna; K Nowicka
Journal:  J Neurol       Date:  1976-10-04       Impact factor: 4.849

Review 9.  Neuroimmunology in multiple sclerosis.

Authors:  C L Cazzullo; D Caputo; C Parravicini
Journal:  Ital J Neurol Sci       Date:  1983-06

10.  Viral Impact in Autoimmune Diseases: Expanding the "X Chromosome-Nucleolus Nexus" Hypothesis.

Authors:  Wesley H Brooks
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.